Webdisclosure.com

ZOMEDICA CORP. (NYSE:ZOM)

17/03/2023 11:30

Zomedica Appoints New Chief Financial Officer

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

15/03/2023 21:45

Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

08/03/2023 12:30

Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

09/02/2023 12:30

Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

24/01/2023 12:00

Zomedica to Participate in the Lytham Partners Investor Select Conference

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

18/01/2023 12:00

Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

17/01/2023 12:00

Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

11/01/2023 12:00

Zomedica to Present at Sidoti Virtual Investor Conference January 18-19

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

15/12/2022 12:30

Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans

Voir tous les communiqués de Zomedica Corp.

ZOMEDICA CORP. (NYSE:ZOM)

14/11/2022 22:20

Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities

Voir tous les communiqués de Zomedica Corp.

1
2
3
4
5
6
7
8
9
10